6 news items
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
published here constitutes a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer
CORT
HALO
MAIA
6 Jun 24
not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer or solicitation
MAIA Biotechnology (MAIA) to Showcase Groundbreaking Telomere-Targeting Cancer Treatments at BIO International Convention 2024
AFMD
ALBT
BPTH
4 Jun 24
that no content published here constitutes a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax
MAIA Biotechnology Inc (MAIA) Stock Surges as Company Prepares to Present Promising Data at BIO International Convention
CRL
IQV
MAIA
31 May 24
a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice
MAIA Biotechnology's Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market
MAIA
22 May 24
of 25% federal tax credit for expenses incurred in conducting clinical research within the U.S., and waiver of Prescription Drug User Fee Act (PDUFA) fees
wtqy45wpryxwd6nurlag8m1gxshl0uaslu4g6xz1ey48svtfskpwosn 494
ABBV
JNJ
LLY
21 May 24
or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content
- Prev
- 1
- Next